Table 4.
The 10 potential major drug interactions most commonly detected at admission
Major drug interactions | Documentation status | Potential risk | n (%) |
Aspirin-enoxaparin | Good | Increased risk of bleeding | 21 (7.3) |
Clopidogrel-omeprazole | Excellent | Increased risk for thrombosis | 11 (3.8) |
Clopidogrel-enoxaparin | Fair | Increased risk of bleeding | 10 (3.5) |
Fentanyl-morphine | Fair | Increased risk of CNS depression | 10 (3.5) |
Aspirin-clopidogrel | Fair | Increased risk of bleeding | 8 (2.8) |
Fentanyl-lorazepam | Fair | Increased risk of CNS depression | 6 (2.1) |
Omeprazole-citalopram | Fair | Increased risk of QT interval prolongation | 6 (2.1) |
Citalopram-enoxaparin | Good | Increased risk of bleeding | 5 (1.7) |
Lorazepam-zolpidem | Fair | Increased risk of CNS depression | 5 (1.7) |
Quetiapine-trazodone | Fair | Increased risk of QT interval prolongation | 5 (1.7) |
Total | 87/289 (30.1) |
CNS, central nervous system.